High dose chemotherapy (HDC) with peripheral blood stem cell (PBSC) transplantation for patients (pts) with advanced ovarian cancer.

被引：0
|
作者：
Bojko, P
Hilger, R
Schenlen, ME
Oberhoff, C
Schindler, AE
Seeber, S
机构：
[1] Univ Essen Gesamthsch, W German Canc Ctr, Dept Internal Med, Essen, Germany
[2] Univ Essen Gesamthsch, Dept Obstet & Gynaecol, Essen, Germany
来源：
ANNALS OF ONCOLOGY | 2000年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
365P
引用
收藏
页码：82 / 82
页数：1
相关论文
共 50 条
  • [41] Tandem high-dose therapy with peripheral blood stem cell transplantation in 105 patients with high risk breast cancer.
    Hohaus, S
    Martin, S
    Schneeweiss, A
    Huober, J
    Fersis, N
    Goldschmidt, H
    Wallwiener, D
    Bastert, G
    Haas, R
    BLOOD, 1997, 90 (10) : 4560 - 4560
  • [42] Multiple high dose chemotherapy with peripheral blood stem cells (PBSC) reinfusion in high risk breast cancer
    Cocorocchio, E
    Peccatori, F
    Zimatore, M
    Ferrucci, PF
    Cinieri, S
    Agazzi, A
    Martinelli, G
    ANNALS OF ONCOLOGY, 1998, 9 : 9 - 9
  • [43] Autologous peripheral blood stem cell rescue following high dose chemotherapy in inflammatory breast cancer.
    Smith, SM
    Grinblatt, D
    Huffman-Dertz, S
    Williams, SF
    JOURNAL OF INVESTIGATIVE MEDICINE, 1999, 47 (07) : 223A - 223A
  • [44] Abnormal fibrinolysis in patients receiving high-dose therapy followed by peripheral blood stem cell (PBSC) transplantation
    Belotti, D
    Villa, A
    Parma, M
    Pogliani, EM
    THROMBOSIS AND HAEMOSTASIS, 1997, : PS516 - PS516
  • [45] Taxanes in salvage and high-dose chemotherapy and autologous peripheral blood stem cell transplantation in patients with advanced germ cell tumors
    Korenkova, I.
    Sakalo, A.
    Sakalo, V.
    Yakovlev, P.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S652 - S652
  • [46] High dose busulphan (BU), melphalan (Mel) thiotepa (TT), and IL-2 activated peripheral blood stem cells (PBSC) for the treatment of advanced ovarian cancer.
    Badros, AZ
    Ebadi, M
    Hassan, R
    Frankel, S
    Meehan, K
    Cairo, M
    BLOOD, 1998, 92 (10) : 360B - 360B
  • [47] High-dose chemotherapy and autologous peripheral blood stem cell transplantation in metastatic breast cancer.: Updated results of a single center
    Okan, K.
    Komurcu, S.
    Arpaci, F.
    Ozet, A.
    Beyzadeoglu, M.
    Ulutin, C.
    Ataergin, S.
    EJC SUPPLEMENTS, 2005, 3 (02): : 132 - 132
  • [48] RATIONALE FOR VERY HIGH-DOSE CHEMOTHERAPY WITH PERIPHERAL-BLOOD STEM-CELL SUPPORT IN ADVANCED OVARIAN-CANCER
    PANICI, PB
    SCAMBIA, G
    BAIOCCHI, G
    LAURELLI, G
    GREGGI, S
    BATTAGLIA, F
    RAGUSA, G
    SALERNO, G
    GALLO, A
    CENTO, R
    MANCUSO, S
    HAEMATOLOGICA, 1990, 75 : 87 - 89
  • [49] Triple (T) high-dose chemotherapy (HDC) with autologous blood stem cell rescue (ABSR) is not superior to double (D) HDC with ABSR in patients (pts) with metastatic breast cancer (MBC).
    Schneeweiss, A
    Görner, R
    Hensel, M
    Egerer, G
    Khbeis, T
    Solomayer, E
    Haas, R
    Grischke, EM
    Ho, A
    Bastert, G
    ANNALS OF ONCOLOGY, 2000, 11 : 30 - 31
  • [50] HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS PERIPHERAL STEM-CELL SUPPORT IN ADVANCED OVARIAN-CANCER
    BENEDETTIPANICI, P
    GREGGI, S
    SCAMBIA, G
    SALERNO, MG
    MENICHELLA, G
    PIERELLI, L
    FODDAI, ML
    BIZZI, B
    MANCUSO, S
    ANNALS OF MEDICINE, 1995, 27 (01) : 133 - 138
12345